Dhinaca endoscope-yada caafimaadka ee gudaha, endoscope-yada dabacsan iyo kuwa adagba waxaa muddo dheer ku badnaa alaabada dibadda laga keeno. Si kastaba ha ahaatee, iyadoo la horumarinayo tayada gudaha iyo horumarka degdegga ah ee beddelka soo dejinta, Sonoscape iyo Aohua waxay ka soo muuqdaan shirkado matalaya qaybta endoscope-yada dabacsan.
Suuqa daawada ee endoscope-ka ayaa wali waxaa ku badan waxyaabaha laga soo dejiyo
Heerka guud ee farsamada iyo geeddi-socodka warshadaynta ee warshadaha endoscope-ka caafimaadka ee Shiinaha ayaa muddo dheer dib uga dhacay kuwa dalalka horumaray, laakiin shirkado badan ayaa horumar weyn ka sameeyay qaar ka mid ah qaybaha hoose, iyagoo si tartiib tartiib ah ula qabsanaya alaabada laga soo dhoofiyo bartamaha ilaa sare ee tilmaamayaasha waxqabadka asaasiga ah sida caddeynta sawirka iyo taranka midabka. Sannadkii 2017, heerka deegaan ee warshadaha endoscope-ka caafimaadka ee Shiinaha wuxuu ahaa 3.6% oo keliya, taasoo kor u kacday 6.9% sannadkii 2021, waxaana la filayaa inay gaarto 35.2% sannadka 2030.
Heerka guryaha ee endoscope-yada caafimaadka ee Shiinaha(Soo dejinta & Gudaha)
Endoscope Adag: Sannadkii 2022, cabbirka suuqa ee suuqa Endoscope Adag ee Shiinaha waa qiyaastii 9.6 bilyan oo yuan, noocyada la soo dejiyo sida Karl Storz, Olympus, Stryker, iyo Wolf waxay ka yihiin wadarta guud ee 73.4% saamiyada suuqa. Noocyada gudaha ayaa bilaabmay goor dambe, laakiin shirkadaha gudaha ee ay matasho Mindray si degdeg ah ayay u kordheen, taasoo ka dhigan qiyaastii 20% saamiyada suuqa.
Flexibe Endoscope: Sanadka 2022, cabbirka suuqa ee suuqa endoscope dabacsan ee Shiinaha waa qiyaastii 7.6 bilyan oo yuan, nooca Olympus ee la soo dejiyona waa kan kaliya, kaasoo ka dhigan 60.40% saamiga suuqa gudaha, Fuji ee Japan-na waxay gashay kaalinta labaad iyadoo leh saami dhan 14%. Shirkadaha gudaha waxaa matalayaSonoscapeAohua waxay jebisay awoodda tiknoolajiyadda shisheeye waxayna si degdeg ah u kacday. Sannadkii 2022, Sonoscape waxay gashay kaalinta koowaad ee Shiinaha iyadoo leh saami dhan 9% iyo saddexaad suuqa; Aohua waxay gashay kaalinta labaad ee Shiinaha iyadoo leh saami dhan 5.16% iyo shanaad suuqa.
Matrix-ka Badeecada
Aohua waxay diiradda saartaa endoscope-yada dabacsan ee caafimaadka iyo waxyaabaha la isticmaalo ee durugsan. Alaabteeda waxaa si weyn loogu isticmaalaa waaxaha caafimaadka sida gastroenterology, daawada neefsashada, otolaryngology, cudurada dumarka, iyo daawada degdegga ah.
Shirkaddu waxay samaysay afar khad oo waaweyn oo wax soo saar ah, oo ay ku jiraan ultrasound, endoscopy, qalliin yar oo gudaha ah, iyo faragelinta wadnaha iyo xididdada dhiigga. Qaab-dhismeedka horumarinta khadadka wax soo saarka badan ayaa markii hore la sameeyay. Kuwaas waxaa ka mid ah ganacsiga endoscopy wuxuu noqday mid ka mid ah qaybaha ganacsiga ugu muhiimsan ee shirkadda waana isha ugu weyn ee kobaca shirkadda. Ganacsiga endoscopy-ga ee shirkaddu wuxuu inta badan ku salaysan yahay endoscopes dabacsan, wuxuuna sidoo kale ku lug leeyahay isticmaalka endoscopy-ga ee meelaha fogfog iyo endoscopes adag.
Qaab-dhismeedka badeecada Endoscope ee dabacsan ee shirkad kasta
Sonoscape iyo Aohua labaduba waxay sameeyeen qaab-dhismeed dhammaystiran oo ku saabsan cilmiga endoscope-yada jilicsan, nidaaminta badeecadooduna waxay u dhowdahay tii Olympus, oo ah hoggaamiyaha adduunka ee endoscope-yada dabacsan.
Badeecada ugu caansan Aohua ee AQ-300 waxay ku jirtaa suuqa ugu sarreeya, AQ-200 oo leh waxqabad iyo qiimo dheellitiran ayaa loogu talagalay suuqa dhexe, badeecadaha aasaasiga ah sida AQ-120 iyo AQ-100 waxay ku habboon yihiin suuqa hoose.
Badeecada dabacsan ee endoscope-ka Sonoscape ee HD-580 ayaa ku jirta suuqa ugu sarreeya, badeecada ugu badan ee hadda la iibinayo waa HD-550, oo ku taal bartamaha. Waxay leedahay kayd badeecooyin oo qani ah suuqyada hoose iyo kuwa dhexe.
Isbarbardhigga waxqabadka ee endoscope-yada heerka dhexe iyo heerka sare
Badeecadaha endoscope-ka ee heerka sare ah ee Sonoscape iyo Aohua ayaa durba la qabsaday noocyada caalamiga ah ee hormuudka ka ah dhinacyo badan oo waxqabadka ah. Inkasta oo badeecooyinka heerka sare ah ee labada ah lagu soo bandhigay suuqa muddo gaaban, haddana si degdeg ah ayay ugu socdaan suuqa heerka sare ah iyagoo ku tiirsan waxqabad tayo sare leh iyo waxqabad kharash badan leh.
Waqtigan xaadirka ah, suuqa gudaha ee Aohua iyo Sonoscape wuxuu inta badan ku yaal isbitaallada sare iyo kuwa hoose. Isla mar ahaantaana, iyagoo ku tiirsan soo saarista alaabada heerka sare ah, waxay si dhakhso ah u qabsadeen suuqa heerka sare ah oo ka sarreeya heerka sare sannadihii ugu dambeeyay, alaabadoodana waxaa si weyn looga aqoonsaday suuqa. Kuwaas waxaa ka mid ah, Sonoscape endoscopes waxay galeen in ka badan 400 oo isbitaallo heer sare ah marka la gaaro 2023; Aohua waxay ku tiirsanayd kor u qaadista nidaamka endoscope-ka ee AQ-300 4K ee qeexitaanka sare leh sannadkii 2024, waxayna rakibtay (oo ay ku jiraan dalabyo guuleystay) 116 isbitaallo heer sare ah sannadkaas (73 iyo 23 isbitaallo heer sare ah ayaa la rakibay 2023 iyo 2022 siday u kala horreeyaan).
Dakhliga hawlgalka
Sannadihii ugu dambeeyay, waxqabadka Sonoscape iyo Aohua ayaa si xawli ah u korayay, gaar ahaan ganacsiyada la xiriira endoscopy-ga. Inkasta oo ay jiri doonaan isbeddello sanadka 2024 sababtoo ah saameynta siyaasadaha warshadaha, haddana hirgelinta siyaasadaha cusboonaysiinta qalabka ee xiga ayaa sii wadi doona soo kabashada baahida suuqa.
Dakhliga baaritaanka endoscopy-ga ee Aohua ayaa ka kordhay 160 milyan oo yuan sannadkii 2018 ilaa 750 milyan oo yuan sannadkii 2024. Sannadkii 2020, saameynta cudurka faafa awgeed, dakhliga sanadka ayaa hoos u dhacay 11.6%. Tan iyo markii la sii daayay alaabada heerka sare ah sannadkii 2023, kobaca waxqabadka ayaa sii kordhay. Sannadkii 2024, heerka kobaca ayaa hoos u dhacay sababtoo ah saameynta siyaasadaha la xiriira qalabka caafimaadka ee gudaha.
Dakhliga guud ee Sonoscape Medical ayaa ka kordhay 1.23 bilyan oo yuan sannadkii 2018 ilaa 2.014 bilyan oo yuan sannadkii 2024. Kuwaas waxaa ka mid ah, dakhliga ganacsiyada la xiriira baaritaanka endoscopy ayaa ka kordhay 150 milyan oo yuan sannadkii 2018 ilaa 800 milyan oo yuan sannadkii 2024. Xitaa saameynta cudurka faafa ee sannadkii 2020, weli waxay gaartay kobac gaar ah, laakiin iyadoo ay saameyn ku yeelatay siyaasadaha la xiriira qalabka caafimaadka sannadkii 2024, ganacsiga la xiriira baaritaanka endoscopy ayaa si yar hoos ugu dhacay.
Marka laga hadlayo dakhliga guud ee shirkadda, wadarta guud ee ganacsiga Sonoscape aad ayay uga badan tahay tan Aohua, laakiin heerka kobaca ayaa wax yar ka hooseeya kan Aohua. Ganacsiga endoscopy-ga, ganacsiga la xiriira endoscopy-ga Sonoscape wali wuu ka weyn yahay kan Aohua. Sanadka 2024, dakhliga ganacsiga ee la xiriira endoscopy-ga Sonoscape iyo Aohua wuxuu noqon doonaa 800 milyan iyo 750 milyan siday u kala horreeyaan; marka la eego heerka kobaca, ganacsiga endoscopy-ga Sonoscape wuxuu si ka dhaqso badan uga koray Aohua ka hor 2022, laakiin tan iyo 2023, sababtoo ah kororka mugga alaabada heerka sare ah ee Aohua, heerka kobaca Aohua wuxuu dhaafay heerka kobaca ganacsiga endoscopy-ga Sonoscape.
Isbarbardhigga dakhliga hawlgalka ee Aohua iyo Sonoscape
(100 milyan oo Yuan)
Suuqa endoscope-ka caafimaadka gudaha waxaa ku badan noocyada la soo dejiyo. Soo-saareyaasha gudaha oo ay matalaan Sonoscape iyo Aohua ayaa si xawli ah u koraya oo si tartiib tartiib ah u beddelaya waxyaabaha la soo dejiyo. Ganacsiga gudaha waa aagga ganacsiga ugu muhiimsan ee Sonoscape iyo Aohua. Sannadkii 2024, ganacsiga gudaha wuxuu u dhigmaa 51.83% iyo 78.43% mugga ganacsiga Sonoscape iyo Aohua siday u kala horreeyaan. Isla mar ahaantaana, shirkadaha hormuudka ka ah gudaha oo ay matalaan Sonoscape iyo Aohua ayaa si firfircoon u hawlgelinaya suuqyada dibadda, mugga ganacsiga ee endoscope-yada caafimaadka gudaha ee suuqa caalamiga ahna wuu sii kordhayaa.
Ganacsiga caalamiga ah ee Endoscope-ka ee Aohua ayaa sii kordhaya, laga bilaabo 100 milyan oo yuan sannadkii 2020 ilaa 160 milyan oo yuan sannadkii 2024, laakiin saamigeeda ganacsi ee caalamiga ah ayaa hoos uga dhacay 36.8% sannadkii 2020 ilaa 21.6% sannadkii 2024.
Ganacsiga caafimaadka ee Sonoscape wuxuu ka kooban yahay qaybo badan, qaab-dhismeedka gudaha iyo dibadda ee ganacsiga endoscope-ka si gaar ah looma shaacin. Guud ahaan mugga ganacsiga caalamiga ah ee shirkaddu wuu sii kordhayaa, laga bilaabo 500 milyan oo yuan sannadkii 2020 ilaa 970 milyan oo yuan sannadkii 2024, saamiga ganacsiga caalamiga ahna waa mid deggan, inta u dhaxaysa 43% iyo 48%.
Isbarbardhigga ganacsiga caalamiga ah oo ay fureen Aohua iyo Sonoscape
(100 milyan oo Yuan)
Saamiga ganacsiga caalamiga ah ee ay fureen Aohua iyo Sonoscape
Heerka faa'iidada
Maadaama labada shirkadood ee hormuudka ka ah dawooyinka gudaha ee Flexible endoscopes, Aohua iyo Sonoscape ay ilaashadeen faa'iido guud oo aad u sarreysa iyagoo adeegsanaya alaabadooda tayada sare leh iyo kartidooda ganacsi. Faa'iidada guud ee Aohua ayaa si tartiib tartiib ah uga korodhay 67.4% sannadkii 2020 ilaa 73.8% sannadkii 2023, laakiin waxay hoos ugu dhici doontaa 68.2% sannadka 2024; Faa'iidada guud ee Sonoscape ayaa si tartiib tartiib ah uga korodhay 66.5% sannadkii 2020 ilaa 69.4% sannadkii 2023, laakiin waxay hoos ugu dhici doontaa 63.8% sannadka 2024; Faa'iidada guud ee Sonoscape ayaa wax yar ka hooseysa tan Aohua, laakiin waxay inta badan sabab u tahay kala duwanaanshaha qaab-dhismeedka ganacsiga. Marka la eego ganacsiga endoscopy oo keliya, faa'iidada guud ee Sonoscape ayaa ka korodhay 65.5% sannadkii 2020 ilaa 74.4% sannadkii 2023, laakiin waxay hoos ugu dhici doontaa 66.6% sannadka 2024. Faa'iidada guud ee labada ganacsi ee endoscopy waa la barbar dhigi karaa.
Isbarbardhigga faa'iidada guud ee u dhaxaysa Aohua iyo Sonoscape
Maalgashiga R&D
Labada Aohua iyo Sonoscape labaduba waxay muhiimad weyn siiyaan cilmi-baarista iyo horumarinta wax soo saarka. Heerka kharashka cilmi-baarista iyo horumarinta ee Aohua wuxuu ka kordhay 11.7% sannadkii 2017 ilaa 21.8% sannadkii 2024. Heerka kharashka cilmi-baarista iyo horumarinta ee Sonoscape wuxuu ahaa inta u dhaxaysa 18% iyo 20% sannadihii ugu dambeeyay, laakiin sannadkii 2024, maalgashiga cilmi-baarista iyo horumarinta ayaa sii kordhay, isagoo gaaray 23.5%.
Isbarbardhigga kharashka cilmi-baarista iyo horumarinta ee u dhexeeya Aohua iyo Sonoscape (million yuan)
Isbarbardhigga maalgashiga shaqaalaha cilmi-baarista iyo horumarinta ee u dhexeeya Aohua iyo Sonoscape
Labada Aohua iyo Sonoscape waxay muhiimad weyn siiyaan maalgashiga shaqaalaha cilmi-baarista iyo horumarinta. Sannadihii ugu dambeeyay, qoondaynta shaqaalaha cilmi-baarista iyo horumarinta ee Kaili waxay ahayd mid deggan oo ah 24%-27% tirada guud ee shaqaalaha, halka qoondaynta shaqaalaha cilmi-baarista iyo horumarinta ee Aohua ay ahayd mid deggan oo ah 18%-24% tirada guud ee shaqaalaha.
Annaga, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., waa soo-saare ku takhasusay isticmaalka endoscopic-ga, sidaqalabka lagu baadho unugyada, hemoclip, Dabin polyp ah, irbad daaweynta sclerotherapy, Kateetarka buufinta, Burushyada unugyada, hagaha, dambiisha soo celinta dhagaxa, kateetarka dheecaanka sanka ee biliary-ga,galka marin u helidda kaadi mareenkaiyogalka marin u helida kaadi mareenka oo leh nuugidiwm. kuwaas oo si weyn loogu isticmaalo gudahaEMR, ESD, ERCPBadeecadahayagu waa kuwa haysta shahaadada CE, warshadeenuna waa kuwo haysta shahaadada ISO. Badeecadahayagu waxaa loo dhoofiyay Yurub, Waqooyiga Ameerika, Bariga Dhexe iyo qayb ka mid ah Aasiya, waxayna si ballaaran u helaan macaamiisha aqoonsiga iyo ammaanta!
Waqtiga boostada: Luulyo-14-2025